Related Experiment Video
Updated: Aug 9, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
IL-4 inhibits P-glycoprotein in normal and malignant NK cells
A R Tambur1, P N Markham, H M Gebel
1Department of Pathology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, IL, USA.
Abstract:
Patients presenting with a natural killer (NK) cell leukemia generally have a poor prognosis. NK cell tumors are generally resistant to numerous chemotherapeutic drugs and even combination chemotherapy usually results in only short term remissions. The drug resistance of NK cell leukemias may be at least partially explained by their expression of the multidrug resistant transporter, P-glycoprotein (Pgp). In this study, we demonstrate that the expression and function of Pgp activity on NK cells (leukemic and normal) can be reversed with IL-4.
Insights
Natural killer (NK) cell leukemia has a poor prognosis due to drug resistance. Interleukin-4 (IL-4) therapy can reverse P-glycoprotein (Pgp) activity, potentially improving treatment outcomes for NK cell malignancies.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Natural killer (NK) cell leukemia is an aggressive malignancy with limited treatment options.
- Patients with NK cell leukemia often experience poor prognoses and short-term remissions.
- Drug resistance in NK cell tumors is frequently associated with P-glycoprotein (Pgp) expression.
Purpose of the Study:
- To investigate the effect of Interleukin-4 (IL-4) on P-glycoprotein (Pgp) expression and function in NK cells.
- To explore potential therapeutic strategies for overcoming drug resistance in NK cell leukemia.
Main Methods:
- Assessing Pgp expression and activity in both normal and leukemic NK cells.
- Treating NK cells with IL-4 and evaluating changes in Pgp.
Main Results:
- IL-4 treatment was found to reverse the expression and function of Pgp on NK cells.
- This reversal was observed in both normal and malignant NK cell populations.
Conclusions:
- IL-4 demonstrates potential as a therapeutic agent to overcome Pgp-mediated drug resistance in NK cell leukemia.
- Targeting Pgp with IL-4 may offer a novel strategy to improve treatment efficacy for patients with NK cell malignancies.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

